Collegium Pharmaceutical (COLL) EBITDA Margin (2016 - 2026)
Collegium Pharmaceutical (COLL) posted EBITDA Margin of 34.25% for Q2 2026, down 14.53 percentage points from 48.78% a year earlier and down 10.62 percentage points from the prior quarter.
Powered by 
Analysis
Collegium Pharmaceutical (COLL) EBITDA Margin (2016 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA Margin at Collegium Pharmaceutical was 48.38%, up 0.13 percentage points year-over-year; for FY2025, it came in at 51.98%, down 1.72 percentage points from FY2024.
- Annual EBITDA Margin shows a five-year change of +13.98 percentage points (FY2020 to FY2025).
- In prior years, Collegium Pharmaceutical's EBITDA Margin was 53.69% in FY2024 (-2.10 pp), 55.79% in FY2023 (+18.66 pp), 37.13% in FY2022 (+5.87 pp) and 31.26% in FY2021 (-6.73 pp).
- The Q2 2026 figure stands as the lowest quarterly EBITDA Margin since Q1 2022.
- On a year-over-year basis, EBITDA Margin increased in three of the last eight quarters, with an average year-over-year change of -5.98 percentage points.
- The strongest year-over-year quarter for EBITDA Margin in the past five years was Q4 2022, with a gain of 104.10 percentage points; the weakest was Q4 2021, with a drop of 103.83 percentage points.
- According to Business Quant data, EBITDA Margin for the three prior quarters was 44.87% (Q1 2026), 57.02% (Q4 2025) and 56.65% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Collegium Pharmaceutical | 735.44 Mn | -488.33 Mn | 110.29 Mn | 34.25% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 34.25% |
| Mar 31, 2026 | 44.87% |
| Dec 31, 2025 | 57.02% |
| Sep 30, 2025 | 56.65% |
| Jun 30, 2025 | 48.78% |
| Mar 31, 2025 | 44.02% |
| Dec 31, 2024 | 52.01% |
| Sep 30, 2024 | 48.08% |
| Jun 30, 2024 | 57.09% |
| Mar 31, 2024 | 58.59% |
| Dec 31, 2023 | 64.88% |
| Sep 30, 2023 | 60.10% |
| Jun 30, 2023 | 54.59% |
| Mar 31, 2023 | 43.46% |
| Dec 31, 2022 | 42.32% |
| Sep 30, 2022 | 46.06% |
| Jun 30, 2022 | 39.88% |
| Mar 31, 2022 | 11.49% |
| Dec 31, 2021 | -61.78% |
| Sep 30, 2021 | 39.82% |
API Access
Collegium Pharmaceutical EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=COLL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "COLL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=COLL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();